We would like to present our recent REQUITE video for Health Professionals:
The goal of the REQUITE project is to validate known predictors of adverse reactions and develop the statistical models to become clinically useful.
This multi-centre observational study will be the largest study of its kind collecting blood samples and standardised data longitudinally from over 4,400 cancer patients. It will enable validation of models that predict a patient’s risk of developing long-term side-effects following radiotherapy. It will be a unique (eventually widely accessible) resource for studying the relationships between side-effect endpoints and between side-effects and quality-of-life. It is known that genetics influence a patient’s risk of developing side-effects and a number of assays/approaches have been explored to assess a patient’s sensitivity to radiation. This prospective observational study will allow for the validation of the most promising biomarkers/approaches.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 601826